Article
No evidence that GATA3 rs570613 SNP modifies breast cancer risk.
Breast cancer research and treatment - 1 Sept 2009
Johnatty Sharon E, Couch Fergus J, Fredericksen Zachary, Tarrell Robert, Spurdle Amanda B, Beesley Jonathan, Chen Xiaoqing, Gschwantler-Kaulich Daphne, Singer Christian F, Fuerhauser Christine, Fink-Retter Anneliese, Domchek Susan M, Nathanson Katherine L, Pankratz Vernon S, Lindor Noralane M, Godwin Andrew K, Caligo Maria A, Hopper John, Southey Melissa C, Giles Graham G, Justenhoven Christina, Brauch Hiltrud, Hamann Ute, Ko Yon-Dschun, Heikkinen Tuomas, Aaltonen Kirsimari, Aittomäki Kristiina, Blomqvist Carl, Nevanlinna Heli, Hall Per, Czene Kamila, Liu Jianjun, Peock Susan, Cook Margaret, Platte Radka, Gareth Evans D, Lalloo Fiona, Eeles Rosalind, Pichert Gabriella, Eccles Diana, Davidson Rosemarie, Cole Trevor, Cook Jackie, Douglas Fiona, Chu Carol, Hodgson Shirley, Paterson Joan, Hogervorst Frans B L, Rookus Matti A, Seynaeve Caroline, Wijnen Juul, Vreeswijk Maaike, Ligtenberg Marjolijn, van der Luijt Rob B, van Os Theo A M, Gille Hans J P, Blok Marinus J, Issacs Claudine, Humphreys Manjeet K, McGuffog Lesley, Healey Sue, Sinilnikova Olga, Antoniou Antonis C, Easton Douglas F, Chenevix-Trench Georgia
Abstract excerpt
GATA-binding protein 3 (GATA3) is a transcription factor that is crucial to mammary gland morphogenesis and differentiation of progenitor cells, and has been suggested to have a tumor suppressor function. The rs570613 single nucleotide polymorphism (SNP) in intron 4 of GATA3 was previously found...
Read the complete abstract on PubMed